Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz

Journal of Clinical Investigation

Volumn 98, Issue 5, 1996, Pages 1210-1217

  O'Dwyer, Peter J ^a,b   Szarka, Christine E ^a   Yao, Kang Shen ^a   Halbherr, Theresa C ^a   Pfeiffer, Gordon R ^a   Green, Frances ^a   Gallo, James M ^a   Brennan, James ^a   Frucht, Harold ^a   Goosenberg, Eric B ^a   Hamilton, Thomas C ^a   Litwin, Samuel ^a   Balshem, Andrew M ^a   Engstrom, Paul F ^a   Clapper, Margie L ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

chemoprevention; DT diaphorase; gene expression; oltipraz; glutamylcysteine synthetase

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; OLTIPRAZ; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGED; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9544250360     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118904     Document Type: Article

References (52)

1. Boring, C.C., T.S. Squires, T. Tong, and S. Montgomery. 1994. Cancer statistics. CA Cancer J. Clin. 44:18-19.
2. Vogelstein, B., E. R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M. Smits, and J.L. Bos. 1987. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:525-32.
3. Lothe, R.A., P. Peltomaki, G.I. Meling, L.A. Aaltonen, M. Nystrom-Lahti, L. Pylkkanner, K. Heindal, T.I. Andersen, P. Moller, T.O. Rognum, et al. 1993. Genomic instability in colorectal cancer: relationship to clincopathological variables and family history. Cancer Res. 53:5849-5852.
4. Jen, J., S.M. Powell, N. Papadopoulos, K.J. Smith, S.R. Hamilton, B. Vogelstein, and R.W. Kinzler. 1994. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54:5523-5526.
5. Hill, M.J. 1995. Dietary factors: the intestinal milieu. In Cancer of the Colon, Rectum, and Anus, A. M. Cohen, S. J. Winawar, M.A. Friedman, and L. Gunderson, editors. McGraw Hill, Inc. New York. 27-34.
6. Fishel, R., M.K. Lescoe, M.R.S. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, and R. Kolodner. 1993. The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell. 75: 1027-1038.
7. Leach, F.S., N.C. Nicolaides, N. Papadopoulos, B. Liu, J. Jen, R. Parsons, P. Pelkomaki, P. Sistoner, L.A. Aaltonen, M. Nystrom-Lahti, et al., 1993. Mutations of a mut S homolog in hereditary non-polyposis colorectal cancer. Cell. 75: 1215-1225.
8. Gupta, I., J. Baptista, W.R. Bruce, C.T. Che, R. Furrer, J.S. Gingerich, A.A. Grey, L. Marai, P. Yates, and J.J. Krepinsky. 1983. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces. Biochemistry. 22:241-245.
9. Sugimura, T. 1985. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat. Res. 150:33-42.
10. Tempero, M. 1986. Bile acids, ornithine decarboxylase, and cell proliferation in colon cancer: a review. Dig. Dis. 4:49-56.
11. Bartram, H.P., W. Scheppach, H. Schmid, A. Hofmann, G. Dusel, F. Richter, A. Richter, and H. Kasper. 1993. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia and pH. Cancer Res. 53:3283-3288.
12. Morizet, J., A. Gonyetta, and G. G. Chabot. 1992. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res. 52:6567-6575.
13. Meister, A. 1983. A selective modification of glulathione metabolism. Science (Wash. DC). 220:472-477.
14. Seidegard, J., R.W. Pero, M.M. Markowitz, G. Roush, D.G. Miller, and E.J. Beattie. 1990. Isoenzymes of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis (Lond.). 11:33-36.
15. Alexandrie, A.K., M.I. Sundberg, J. Seidegard, G. Tornling, and A. Rannug. 1994. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at ouset, gender, and histological cancer types. Carcinogenesis (Lond.). 15:1785-1790.
16. Szarka, C.E., G.R. Pfeiffer, S.T. Hum, L.C. Everly, A.M. Balshem, D.F. Moore, S. Litwin, E.B. Goosenberg, H. Frucht, P.F. Engstrom, and M. Clapper. 1995. Glutathione S-transferase activity and glulathione S-transferase μ expression in subjects at risk for colorectal cancer. Cancer Res. 55:2789-2793.
17. Trock, B., E. Lanza, and P. Greenwald. 1990. Dietary fiber, vegetables and colon cancer: critical review and metaanalysis of the epidemiologic evidence. J. Natl. Cancer Inst. 82:650-661.
18. National Research Council, Committee on Diet, Nutrition and Cancer. 1982. National Academy Press, Washington, D.C.
19. Wattenberg, L.W. 1983. Inhibition of neoplasia by minor dietary constituents. Cancer Res. 43:2448-2453.
20. Coldilz, G.A., L.G. Branch, R.J. Lipnick, W.C. Willett, B. Rosner, B.M. Posner, and C.H. Hennekens. 1985. Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am. J. Clin. Nutr. 41: 32-36.
21. Kensler, T.W., N.E. Davidson, J.D. Groopman, B.D. Roebuck, H.J. Prochaska, and P. Talalay. 1993. Chemoprotection by inducers of electrophile detoxication enzymes. Basic Life Sci. 61:127-136.
22. Zhang, Y., P. Talalay, C.G. Cho, and G.H. Posner. 1992. A major inducer of protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA. 89:2399-2403.
23. Gentilini, M., B. Duflo, D. Richard-Lenoble, G. Brucker, M. Danis, G. Niel, and Y. Meunier. 1980. Assessment of RP35972 (oltipraz) a new antischistosomal drug against Schistosoma hematobium. Schistosoma mansoni, and Schistosoma intercalatum. Acta Trop. 37:271-274.
24. Wattenberg, L.W., and E. Bueding. 1986. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) on carcinogenesis induced by benzo(a)pyrene, diethylnitrosamine, and uracil mustard. Carcinogenesis (Lond). 7:1379-1381.
25. Rao, C.V., K. Tokoma, G. Kelloff, and B.S. Reddy. 1991. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis (Lond.). 12:1051-1055.
26. Rao, C.V., A. Rivenson, M. Katiwalla, G.J. Kelloff, and B.S. Reddy. Chemopreventive effect of oltipra/ during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 53: 2502-2506.
27. Kensler, T.W., P.A. Egner, P.M. Dolan, J.D. Groopman, and B.D. Roebuck. 1987. Mechanism of protection against aflatoxin tumorigenicity of rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) and related 1,1-dithiole-3-thiones and 1,2-dithiole-3-ones. Cancer Res. 47:4271-4277.
28. Davidson, N.C., P.A. Egner, and T.W. Kensler. 1990. Transcriptional control of glutathione-S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res. 50:2251-2255.
29. Ansher, S.S., P. Dolan, and E. Bueding. 1986. Biochemical effects of dithiolethiones. Food Chem. Toxicol. 24:405-415.
30. Ansher, S.S., P. Dolan, and E. Bueding. 1983. Chemoprotective effects of two dithiolethiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology (NY). 3:932-935.
31. Katz, N., R.S. Rocha, and A. Chaves. 1982. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paolo 24:40-48.
32. Benson, A.B., III. 1993. Oltipraz: a laboratory and clinical review. J. Cell. Biochem. 17(Suppl.)F:278-291.
33. Habig, W.H., and W.B. Jakoby. 1981. Glutathione-S-transferases: assays for differentiation of glutathione-S-transferases. Methods Enzymol. 7:398-405.
34. Griffith, O.W. 1980. Determination of glutathione and glutathione disulfide using glulathione reductase and 2-vinylpyridine. Anal. Biochem. 106:207-212.
35. Ernster, L. 1967. DT-diaphorase. Methods Enzymol. 10:309-317.
36. Miller, S.A., D.O. Dykes, and H.F. Polesky. 1988. A simple sailing our procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
37. Fryer, A.A., L. Zhao, J. Alldersea, W.R. Pearson, and R.C. Strange. 1993. The glutathione S-transferase: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis (Lond.). 14:563-566.
38. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
39. Horikoshi, T., K.D. Danenberg, T.H. W. Stadlbauer, M. Volkenandt, L.C. Shea, K. Aigner, B. Gustavsson, L. Leichman, R. Frosing, M. Ray, et al., 1992. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res. 52:108-116.
40. Yao, K.-S., A.K. Godwin, S.W. Johnson, R.F. Ozols, P.J. O'Dwyer, and T.C. Hamilton. 1995. Evidence for altered regulation of γ-glutamylcysteiene synthetase gene expression among cisplatin-sensitive and -resistant human ovarian cancer cell lines: changes in transcription factor expression and function. Cancer Res. 55:4367-4374.
41. Jaiswal, A.K. W.O. McBride, M. Adesnik, and D.W. Nebert. 1988. Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase, cDNA sequence and localization of gene to chromosome 16. J. Biol. Chem. 263:13572-13578.
42. Ng, S.-Y., P. Gunning, R. Eddy, R., P. Ponte, J. Leavitt, T. Shows, and L. Kedes. 1985. Evolution of the functional human β-actin gene and its multipseudogene family: conservation of non-coding regions and chromosomal dispersion of pseudogenes. Mol. Cell Biol. 5:2720-2732.
43. Board, P.G. 1980. Biochemical genetics of glutathione S-transferase in man. Ann. Hum. Genet. 33:36-43.
44. Strange, R.C., G.C. Faulder, B.A. Davis, R. Hume, J.A. Brown, W. Cotton, and D.A. Hopkinson. 1984. The human glulathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isoenzymes. Ann. Hum. Genet. 48:11-20.
45. Lafuente, A., F. Pujol, P. Carretero, J.P. Villa, and A. Cuchi. 1993. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 68:49-54.
46. Yao, K.-S., A.K. Godwin, R.F. Ozols, T.C. Hamilton, and P.J. O'Dwyer. Variable baseline γ-glutamylcysteiene synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment. Cancer Res. 53:3662-3666.
47. Clapper, M.L., L.C. Everley, L.A. Strobel, A.J. Townsend, and P.F. Engstrom. 1994. Coordinate induction of glutathione S-transferase α, μ and π expression in murine liver after a single administration of oltipraz. Mol. Pharmacol. 45:469-474.
48. Yao, K.-S., and P.J. O'Dwyer. 1995. Involvement of NK-κB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49:275-282.
49. Egner, P.A., T.W. Kensler, T. Prestera, P. Talalay, A.H. Libby, H.H. Joyner, and T.J. Curphey. 1994. Regulation of Phase II enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis (Lond.). 15:177-181.
50. O'Dwyer, P.J., K.-S. Yao, P. Ford, A.K. Godwin, and M. Clayton. 1994. Effects of hypoxia upon detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res. 54:3082-3087.
51. Peters, W.H.M. L. Kock, F.M. Nagengast, and H.M.J. Roelofs. 1990. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem. Pharmacol. 39:591-597.
52. Strange, R.C., B. Matharoo, G.C. Faulder, P. Jones, W. Cotton, J.B. Elder, and M. Deakin. 1991. The human glulathione S-transferases: A case-control study of the incidence of the GST10 phenotype in patients with adenocarcinoma. Carcinogenesis (Lond.). 12:25-28.